Dopaminergic index | Link to schizophrenia | Strength of evidence | |
---|---|---|---|
Drug studies | Effect of DA agonist drugs (eg amphetamine) |
Induces/ worsens psychotic symptoms | + |
Effect of DA receptor antagonists (eg antipsychotics) |
Reduces symptoms | ++ | |
Effect of DA depleting drugs (eg reserpine) |
Reduces symptoms | + | |
Peripheral markers | DA metabolites in CSF and plasma | Increased in schizophrenia | ~ may depend on phase of illness and influenced by peripheral catecholamine metabolism |
Ex vivo studies | Dopamine and DA metabolite levels in brain | Increased in striatum in schizophrenia | + potentially confounded by prior antipsychotic treatment |
Brain imaging studies | DA synthesis and DA release capacity, and baseline DA levels | Increased in striatum in schizophrenia | ++ |
++=found in meta-analysis; += found in well-controlled studies; ~inconsistent findings